Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 34% ± 21% | |
GABAergic neuron | 3 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 94% | 4933.20 | 2475 / 2642 | 91% | 25.39 | 642 / 705 |
adrenal gland | 24% | 406.10 | 62 / 258 | 74% | 79.63 | 171 / 230 |
ovary | 1% | 1.44 | 1 / 180 | 81% | 23.41 | 348 / 430 |
breast | 22% | 111.41 | 99 / 459 | 54% | 7.39 | 606 / 1118 |
prostate | 3% | 10.31 | 7 / 245 | 47% | 11.60 | 238 / 502 |
pancreas | 6% | 21.89 | 20 / 328 | 30% | 2.23 | 54 / 178 |
stomach | 13% | 49.11 | 45 / 359 | 19% | 1.62 | 53 / 286 |
kidney | 0% | 0 | 0 / 89 | 24% | 2.08 | 213 / 901 |
uterus | 2% | 6.21 | 3 / 170 | 17% | 1.65 | 78 / 459 |
intestine | 0% | 0.30 | 1 / 966 | 14% | 1.76 | 75 / 527 |
peripheral blood | 13% | 47.06 | 119 / 929 | 0% | 0 | 0 / 0 |
lung | 3% | 10.18 | 18 / 578 | 9% | 0.65 | 107 / 1155 |
esophagus | 0% | 1.15 | 5 / 1445 | 12% | 1.10 | 22 / 183 |
thymus | 10% | 37.25 | 68 / 653 | 1% | 0.08 | 4 / 605 |
liver | 0% | 0 | 0 / 226 | 9% | 1.30 | 37 / 406 |
skin | 3% | 15.97 | 61 / 1809 | 3% | 0.12 | 15 / 472 |
adipose | 5% | 19.51 | 59 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.25 | 20 / 504 |
eye | 0% | 0 | 0 / 0 | 4% | 0.25 | 3 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.12 | 1 / 45 |
heart | 1% | 5.89 | 10 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 3.47 | 11 / 1335 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.34 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0038007 | Biological process | netrin-activated signaling pathway |
GO_0033564 | Biological process | anterior/posterior axon guidance |
GO_0031175 | Biological process | neuron projection development |
GO_0032589 | Cellular component | neuron projection membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0005042 | Molecular function | netrin receptor activity |
Gene name | UNC5A |
Protein name | Unc-5 netrin receptor A Netrin receptor UNC5 UNC5A protein Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A) |
Synonyms | UNC5H1 KIAA1976 |
Description | FUNCTION: Receptor for netrin required for axon guidance. Functions in the netrin signaling pathway and promotes neurite outgrowth in response to NTN1. Mediates axon repulsion of neuronal growth cones in the developing nervous system in response to netrin. Axon repulsion in growth cones may be mediated by its association with DCC that may trigger signaling for repulsion. It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand. . FUNCTION: Receptor for netrin required for axon guidance. Mediates axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding. . |
Accessions | Q05BS3 H0Y9G2 H0Y8R2 Q6ZN44 ENST00000329542.9 [Q6ZN44-1] ENST00000513890.1 ENST00000509580.2 Q08E75 |